Skip to main content
Log in

CT screening for lung cancer not cost effective in Australia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Australian dollars

Reference

  • Wade S, et al. Estimating the cost-effectiveness of lung cancer screening with low dose computed tomography for high risk smokers in Australia. Journal of Thoracic Oncology : 12 Apr 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.04.006

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

CT screening for lung cancer not cost effective in Australia. PharmacoEcon Outcomes News 803, 10 (2018). https://doi.org/10.1007/s40274-018-4937-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4937-8

Navigation